Search results
Results from the WOW.Com Content Network
Amygdalin (Laetrile) is a toxic drug that is not effective as a cancer treatment". Additionally, "No controlled clinical trials (trials that compare groups of patients who receive the new treatment to groups who do not) of laetrile have been reported." [24] The side effects of laetrile treatment are the symptoms of cyanide poisoning.
Cancer slope factors (CSF) are used to estimate the risk of cancer associated with exposure to a carcinogenic or potentially carcinogenic substance. A slope factor is an upper bound, approximating a 95% confidence limit , on the increased cancer risk from a lifetime exposure to an agent by ingestion or inhalation .
Current Cancer Drug Targets is a peer-reviewed medical journal published by Bentham Science Publishers.The editor-in-chief is Ruiwen Zhang (UH Drug Discovery Institute). The journal covers research on contemporary molecular drug targets involved in cancer, including medicinal chemistry, pharmacology, molecular biology, genomics, and biochemistry.
Ernst Theodore Krebs Jr. (May 17, 1911 – September 8, 1996) was an American promoter of various substances as alternative cures for cancer, including pangamic acid and amygdalin. He also co-patented the semi-synthetic chemical compound closely related to amygdalin called laetrile , which was also promoted as a cancer preventative and cure.
The amygdalin found in apricot seeds has been marketed as an alternative cancer treatment; however, studies have shown it to be ineffective in treating cancer. [3] Cancer Council Australia have commented that "eating apricot kernels in large amounts is not only ineffective for treating cancer, but could also be very dangerous". [8]
An angiogenesis inhibitor is a substance that inhibits the growth of new blood vessels (angiogenesis).Some angiogenesis inhibitors are endogenous and a normal part of the body's control and others are obtained exogenously through pharmaceutical drugs or diet.
ADHD medication tied to 19% lower death risk. An observational study conducted in Sweden, whose results appeared in JAMA in March 2024, further emphasized the positive impact of ADHD medication on ...
It is affiliated with the African Organization for Research and Training in Cancer. The editors-in-chief are Franco M. Buonaguro (Istituto Nazionale Tumori), Sam M. Mbulaiteye (National Cancer Institute) and Maria Lina Tornesello (Istituto Nazionale Tumori). According to the Journal Citation Reports, the journal has a 2021 impact factor of 3. ...